159 related articles for article (PubMed ID: 12542483)
21. Complement gene expression is regulated by pro-inflammatory cytokines and the anaphylatoxin C3a in human tenocytes.
Busch C; Girke G; Kohl B; Stoll C; Lemke M; Krasnici S; Ertel W; Silawal S; John T; Schulze-Tanzil G
Mol Immunol; 2013 Apr; 53(4):363-73. PubMed ID: 23070120
[TBL] [Abstract][Full Text] [Related]
22. Sequential immunophenotypic analysis of mast cells in a case of systemic mast cell disease evolving to a mast cell leukemia.
Escribano L; Orfao A; Villarrubia J; Martín F; Madruga JI; Cuevas M; Velasco JL; Rios A; San Miguel JF
Cytometry; 1997 Apr; 30(2):98-102. PubMed ID: 9149916
[TBL] [Abstract][Full Text] [Related]
23. Bone marrow mast cell immunophenotyping in adults with mast cell disease: a prospective study of 33 patients.
Pardanani A; Kimlinger T; Reeder T; Li CY; Tefferi A
Leuk Res; 2004 Aug; 28(8):777-83. PubMed ID: 15203275
[TBL] [Abstract][Full Text] [Related]
24. Complement-binding proteins are strongly expressed by human preimplantation blastocysts and cumulus cells as well as gametes.
Taylor CT; Johnson PM
Mol Hum Reprod; 1996 Jan; 2(1):52-9. PubMed ID: 9238658
[TBL] [Abstract][Full Text] [Related]
25. Phagocytosis of Mycobacterium leprae by human monocyte-derived macrophages is mediated by complement receptors CR1 (CD35), CR3 (CD11b/CD18), and CR4 (CD11c/CD18) and IFN-gamma activation inhibits complement receptor function and phagocytosis of this bacterium.
Schlesinger LS; Horwitz MA
J Immunol; 1991 Sep; 147(6):1983-94. PubMed ID: 1679838
[TBL] [Abstract][Full Text] [Related]
26. Different expression and mobilisation of the complement regulatory proteins CD35, CD55 and CD59 in neonatal and adult neutrophils.
Lothian C; Dahlgren C; Lagercrantz H; Lundahl J
Biol Neonate; 1997; 72(1):15-21. PubMed ID: 9313830
[TBL] [Abstract][Full Text] [Related]
27. Levels of complement regulatory proteins, CD35 (CR1), CD46 (MCP) and CD55 (DAF) in human haematological malignancies.
Hara T; Kojima A; Fukuda H; Masaoka T; Fukumori Y; Matsumoto M; Seya T
Br J Haematol; 1992 Oct; 82(2):368-73. PubMed ID: 1384649
[TBL] [Abstract][Full Text] [Related]
28. Altered Expression of Complement Regulatory Proteins CD35, CD46, CD55, and CD59 on Leukocyte Subsets in Individuals Suffering From Coronary Artery Disease.
Mishra N; Mohata M; Narang R; Lakshmy R; Hazarika A; Pandey RM; Das N; Luthra K
Front Immunol; 2019; 10():2072. PubMed ID: 31555286
[TBL] [Abstract][Full Text] [Related]
29. Does the aberrant expression of CD2 and CD25 by skin mast cells truly correlate with systemic involvement in patients presenting with mastocytosis in the skin?
Lange M; Żawrocki A; Nedoszytko B; Wasąg B; Niedoszytko M; Jassem E; Nowicki R; Żmijewski MA; Biernat W
Int Arch Allergy Immunol; 2014; 165(2):104-10. PubMed ID: 25402852
[TBL] [Abstract][Full Text] [Related]
30. Detection of differentiation- and activation-linked cell surface antigens on cultured mast cell progenitors.
Schernthaner GH; Hauswirth AW; Baghestanian M; Agis H; Ghannadan M; Worda C; Krauth MT; Printz D; Fritsch G; Sperr WR; Valent P
Allergy; 2005 Oct; 60(10):1248-55. PubMed ID: 16134990
[TBL] [Abstract][Full Text] [Related]
31. CD203c is overexpressed on neoplastic mast cells in systemic mastocytosis and is upregulated upon IgE receptor cross-linking.
Hauswirth AW; Escribano L; Prados A; Nuñez R; Mirkina I; Kneidinger M; Florian S; Sonneck K; Vales A; Schernthaner GH; Sanchez-Muñoz L; Sperr WR; Bühring HJ; Orfao A; Valent P
Int J Immunopathol Pharmacol; 2008; 21(4):797-806. PubMed ID: 19144265
[TBL] [Abstract][Full Text] [Related]
32. Immunophenotypic characterization of bone marrow mast cells in mastocytosis and other mast cell disorders.
Sánchez-Muñoz L; Teodósio C; Morgado JM; Escribano L
Methods Cell Biol; 2011; 103():333-59. PubMed ID: 21722810
[TBL] [Abstract][Full Text] [Related]
33. Mucosal type mast cells express complement receptor type 2 (CD21).
Andrásfalvy M; Prechl J; Hardy T; Erdei A; Bajtay Z
Immunol Lett; 2002 Jun; 82(1-2):29-34. PubMed ID: 12008031
[TBL] [Abstract][Full Text] [Related]
34. In vitro RBC exposure to Plasmodium falciparum has no effect on RBC antigen expression.
Chambers DR; Procter J; Muratova O; Byrne K; Keister D; Shanks D; Magill A; Stroncek D
Transfus Med; 2002 Jun; 12(3):213-9. PubMed ID: 12071878
[TBL] [Abstract][Full Text] [Related]
35. Use of complement regulators, CD35, CD46, CD55, and CD59, on leukocytes as markers for diagnosis of viral and bacterial infections.
Nuutila J; Jalava-Karvinen P; Hohenthal U; Kotilainen P; Pelliniemi TT; Nikoskelainen J; Lilius EM
Hum Immunol; 2013 May; 74(5):522-30. PubMed ID: 23376460
[TBL] [Abstract][Full Text] [Related]
36. Utility of flow cytometric analysis of mast cells in the diagnosis and classification of adult mastocytosis.
Escribano L; Díaz-Agustín B; Bellas C; Navalón R; Nuñez R; Sperr WR; Schernthaner GH; Valent P; Orfao A
Leuk Res; 2001 Jul; 25(7):563-70. PubMed ID: 11377681
[TBL] [Abstract][Full Text] [Related]
37. Expression of complement regulatory molecules and other surface markers on neutrophils from synovial fluid and blood of patients with rheumatoid arthritis.
Jones J; Laffafian I; Cooper AM; Williams BD; Morgan BP
Br J Rheumatol; 1994 Aug; 33(8):707-12. PubMed ID: 8055195
[TBL] [Abstract][Full Text] [Related]
38. Expression of Bcl-2 by human bone marrow mast cells and its overexpression in mast cell leukemia.
Cerveró C; Escribano L; San Miguel JF; Díaz-Agustín B; Bravo P; Villarrubia J; García-Sanz R; Velasco JL; Herrera P; Vargas M; González M; Navarro JL; Orfao A
Am J Hematol; 1999 Mar; 60(3):191-5. PubMed ID: 10072109
[TBL] [Abstract][Full Text] [Related]
39. Isolation and functional assay of the membrane complement inhibitors CD55 (DAF) and CD59 (MIRL).
Parker CJ
Curr Protoc Immunol; 2001 May; Chapter 13():13.5.1-13.5.18. PubMed ID: 18432718
[TBL] [Abstract][Full Text] [Related]
40. C5a, interleukin-8 and tumour necrosis factor-alpha-induced changes in granulocyte and monocyte expression of complement receptors in whole blood and on isolated leukocytes.
Furebring M; Håkansson L; Venge P; Sjölin J
Scand J Immunol; 2006 Mar; 63(3):208-16. PubMed ID: 16499574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
